<https://rdf.molmedb.upol.cz/reference/ref3291> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM476045>,
		<https://rdf.molmedb.upol.cz/interaction/method33>,
		<https://identifiers.org/molmedb/MM475288>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.7b01788"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM475984>,
		<https://identifiers.org/molmedb/MM475286>,
		<https://identifiers.org/molmedb/MM475264>,
		<https://identifiers.org/molmedb/MM475261>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/membrane21>;
	<http://purl.org/ontology/bibo/pmid> "29400967"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Meanwell NA.: Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design. J Med Chem, Volume 61 (14), 2018"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1023445> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .
<https://rdf.molmedb.upol.cz/interaction/int1023602> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .
<https://rdf.molmedb.upol.cz/interaction/int1023590> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .
<https://rdf.molmedb.upol.cz/interaction/int1031336> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .
<https://rdf.molmedb.upol.cz/interaction/int1023698> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .
<https://rdf.molmedb.upol.cz/interaction/int1023588> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3291> .